Matthijs Feuth - UTU Research Portal

Matthijs Feuth

Pulmonary Diseases and Clinical Allergology (Department of Clinical Medicine)

matfeu@utu.fi

Publications

Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study (2022)
- Clinical Microbiology and Infection
Broman Niklas, Feuth Matthijs, Vuorinen Tytti, Valtonen Mika, Hohenthal Ulla, Löyttyniemi Eliisa, Hirvioja Tiina, Jalava-Karvinen Päivi, Marttila Harri, Nordberg Marika, Oksi Jarmo
(Refereed journal article or data article (A1))
Association between Administration of IL-6 Antagonists and Mortality among Patients Hospitalized for COVID-19: A Meta-analysis (2021)
- JAMA: Journal of the American Medical Association
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
(Refereed review article in scientific journal (A2))
Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines (2021)
- International Journal of Tuberculosis and Lung Disease
Feuth Thijs, Patovirta Riitta Liisa, Grierson Sirkku, Danilovitš, Manfred, Viiklepp Piret, Aaltonen Hanna K, Vauhkonen Mikko, Pehme Lea, Vasankari Tuula
(Refereed journal article or data article (A1))
IL-6 and other biomarkers as predictors of severity in COVID-19 (2021)
- Annals of Medicine
Broman N, Rantasärkkä K, Feuth T, Valtonen M, Waris M, Hohenthal U, Rintala E, Karlsson A, Marttila H, Peltola V, Vuorinen T, Oksi J
(Refereed journal article or data article (A1))
Is sleep apnea a risk factor for Covid-19? findings from a retrospective cohort study (2020)
- Sleep Medicine and Disorders: International Journal
Thijs Feuth, Tarja Saaresranta, Antti Karlsson, Mika Valtonen, Ville Peltola, Esa Rintala, Jarmo Oksi
(Refereed journal article or data article (A1))